MEDIUM confidence: 100% data completeness, but the composite (60) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-19.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Net insider -$36K over 180 days (0 open-market buys, 1 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $111 avg across 4 analysts.
Buy-rated share 78% → 75% over ~3 months (-3pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $2.03 | $1.98 | -2.5% |
| May 2026 | $2.27 | $2.52 | +11.0% |
| Feb 2026 | $1.98 | $1.90 | -4.0% |
| Nov 2025 | $1.34 | $1.32 | -1.5% |
| Aug 2025 | $1.31 | $1.25 | -4.6% |
| May 2025 | $0.95 | $0.88 | -7.4% |
| Feb 2025 | $1.27 | $0.89 | -29.9% |
| Nov 2024 | $0.81 | $0.53 | -34.6% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $4.0B— | $4.5B+11.7% | $4.6B+1.8% | $5.8B+26.4% | $9.9B+70.8% |
| EPS (dil.) | $1.46— | $0.55-62.3% | $-0.56-201.8% | $2.33n/m | $5.19+122.7% |
| Free Cash Flow | $196M— | $257M+31.1% | -$61M-123.7% | $878Mn/m | $3.1B+253.6% |
| Gross Margin | 29.1% | 25.1%-4.0pp | 22.4%-2.7pp | 35.7%+13.3pp | 46.5%+10.9pp |
| Operating Margin | 23.2% | 11.5%-11.7pp | 12.5%+1.0pp | 26.8%+14.3pp | 45.1%+18.3pp |
| Net Margin | 15.2% | 5.2%-10.1pp | -5.1%-10.3pp | 17.3%+22.5pp | 26.6%+9.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of -0.7%/yr (revenue basis).
Base free cash flow $1.3B (avg FY2023–FY2025; latest year $3.1B) · equity value $40.4B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 60 for AngloGold Ashanti indicates a moderately attractive stock, driven by strong scores in Growth and Profitability, with the latter exhibiting high returns on equity near 45% and a significant operating margin of 50.4%. The stock's Value score is more neutral, reflecting a P/E of 10.6 and a P/B of 4.5, while Momentum is somewhat subdued due to a recent 3-month decline of 2.2%. The Long-term and Short-term scores diverge by 7 points, with the former suggesting a more favorable outlook.